Phagocyte function and immunological findings in a Wiskott-Aldrich syndrome long-term survivor.
The case reported concerns a 19-year-old man who presented with clinical and laboratory findings compatible with the Wiscott-Aldrich Syndrome. Our patients is the eighth reported case of a long-term survivor with this syndrome. Immunologic studies revealed, in spite of a normal lymphocyte number, an impaired delayed hypersensitivity and a failure of response to mitogens and irradiated allogeneic cells. IgE and IgA levels were high while IgM levels were low. Studies of phagocytic cells showed normal phagocytosis, candidacidal activity, IgG receptors and phagocytic metabolic burst. However, the patient's neutrophils and monocytes responded poorly to chemoattractants and the serum generated less chemotactic activity than normal sera. Detailed studies revealed the presence in the patient's serum of 2 different inhibitors of chemotaxis: a cell-directed inhibitor and an inhibitor of chemotactic factors.
D000328:Adult; D000911:Antibodies, Monoclonal; D000917:Antibody Formation; D002630:Chemotactic Factors / Q000097:blood; D002634:Chemotaxis, Leukocyte; D003167:Complement Activation; D003165:Complement System Proteins / Q000032:analysis; D005500:Follow-Up Studies; D006358:Hot Temperature; D006801:Humans; D007111:Immunity, Cellular; D008297:Male; D009000:Monocytes / Q000276:immunology; D009504:Neutrophils / Q000276:immunology; D010586:Phagocytes / Q000276:immunology*; D014923:Wiskott-Aldrich Syndrome / Q000097:blood / Q000276:immunology* / Q000401:mortality; D015054:Zymosan / Q000494:pharmacology
D000911:Antibodies, Monoclonal; D002630:Chemotactic Factors; D003165:Complement System Proteins; D015054:Zymosan